• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Pharmacology and Toxicology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Pharmacology and Toxicology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Obesity in a model of haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy

    Thumbnail
    View/ Open
    main.PMC4443294.pdf (2.735Mb)

    Show full item record
    
    Author
    Katunga, Lalage Adalaide; Gudimella, Preeti; Efird, Jimmy T.; Abernathy, Scott; Mattox, Taylor A.; Beatty, Cherese; Darden, Timothy M.; Thayne, Kathleen A.; Alwair, Hazaim; Kypson, Alan P.; Virag, Jitka A. I.; Anderson, Ethan J.
    Abstract
    Lipid peroxides and their reactive aldehyde derivatives (LPPs) have been linked to obesity-related pathologies, but whether they have a causal role has remained unclear. Glutathione peroxidase 4 (GPx4) is a selenoenzyme that selectively neutralizes lipid hydroperoxides, and human gpx4 gene variants have been associated with obesity and cardiovascular disease in epidemiological studies. This study tested the hypothesis that LPPs underlie cardio-metabolic derangements in obesity using a high fat, high sucrose (HFHS) diet in gpx4 haploinsufficient mice (GPx4(+/-)) and in samples of human myocardium. METHODS: Wild-type (WT) and GPx4(+/-) mice were fed either a standard chow (CNTL) or HFHS diet for 24 weeks, with metabolic and cardiovascular parameters measured throughout. Biochemical and immuno-histological analysis was performed in heart and liver at termination of study, and mitochondrial function was analyzed in heart. Biochemical analysis was also performed on samples of human atrial myocardium from a cohort of 103 patients undergoing elective heart surgery. RESULTS: Following HFHS diet, WT mice displayed moderate increases in 4-hydroxynonenal (HNE)-adducts and carbonyl stress, and a 1.5-fold increase in GPx4 enzyme in both liver and heart, while gpx4 haploinsufficient (GPx4(+/-)) mice had marked carbonyl stress in these organs accompanied by exacerbated glucose intolerance, dyslipidemia, and liver steatosis. Although normotensive, cardiac hypertrophy was evident with obesity, and cardiac fibrosis more pronounced in obese GPx4(+/-) mice. Mitochondrial dysfunction manifesting as decreased fat oxidation capacity and increased reactive oxygen species was also present in obese GPx4(+/-) but not WT hearts, along with up-regulation of pro-inflammatory and pro-fibrotic genes. Patients with diabetes and hyperglycemia exhibited significantly less GPx4 enzyme and greater HNE-adducts in their hearts, compared with age-matched non-diabetic patients. CONCLUSION: These findings suggest LPPs are key factors underlying cardio-metabolic derangements that occur with obesity and that GPx4 serves a critical role as an adaptive countermeasure.
    URI
    http://hdl.handle.net/10342/5762
    Subject
     4-HNE; 4-hydroxynonenal; BMI; body mass index; CNTL; Coll1a1; HFHS,; reactive nitrogen species; transforming growth factor beta 2; TGF-β2; β-MHC 
    Date
    2015-04
    Citation:
    APA:
    Katunga, Lalage Adalaide, & Gudimella, Preeti, & Efird, Jimmy T., & Abernathy, Scott, & Mattox, Taylor A., & Beatty, Cherese, & Darden, Timothy M., & Thayne, Kathleen A., & Alwair, Hazaim, & Kypson, Alan P., & Virag, Jitka A. I., & Anderson, Ethan J.. (April 2015). Obesity in a model of haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Molecular Metabolism, (4:6), p.493-506. Retrieved from http://hdl.handle.net/10342/5762

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Katunga, Lalage Adalaide, and Gudimella, Preeti, and Efird, Jimmy T., and Abernathy, Scott, and Mattox, Taylor A., and Beatty, Cherese, and Darden, Timothy M., and Thayne, Kathleen A., and Alwair, Hazaim, and Kypson, Alan P., and Virag, Jitka A. I., and Anderson, Ethan J.. "Obesity in a model of haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy". Molecular Metabolism. 4:6. (493-506.), April 2015. August 10, 2022. http://hdl.handle.net/10342/5762.
    Chicago:
    Katunga, Lalage Adalaide and Gudimella, Preeti and Efird, Jimmy T. and Abernathy, Scott and Mattox, Taylor A. and Beatty, Cherese and Darden, Timothy M. and Thayne, Kathleen A. and Alwair, Hazaim and Kypson, Alan P. and Virag, Jitka A. I. and Anderson, Ethan J., "Obesity in a model of haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy," Molecular Metabolism 4, no. 6 (April 2015), http://hdl.handle.net/10342/5762 (accessed August 10, 2022).
    AMA:
    Katunga, Lalage Adalaide, Gudimella, Preeti, Efird, Jimmy T., Abernathy, Scott, Mattox, Taylor A., Beatty, Cherese, Darden, Timothy M., Thayne, Kathleen A., Alwair, Hazaim, Kypson, Alan P., Virag, Jitka A. I., Anderson, Ethan J.. Obesity in a model of haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Molecular Metabolism. April 2015; 4(6) 493-506. http://hdl.handle.net/10342/5762. Accessed August 10, 2022.
    Collections
    • Pharmacology and Toxicology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback